Compare AbCellera Biologics Inc (ABCL) vs 8x8 Inc (EGHT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
AbCellera Biologics Inc vs 8x8 Inc — how do they compare? AbCellera Biologics Inc trades at $9.06 (market cap $2.99B), while 8x8 Inc trades at $2.13 (market cap $309.09M). The key difference: AbCellera Biologics Inc is far larger — about 9.7× 8x8 Inc's market cap, and AbCellera Biologics Inc is trading nearer its 52-week high, 8x8 Inc nearer its low. Which is the better fit depends on your goals.
| ABCL | EGHT | |
|---|---|---|
Market Cap | $2.99B | $309.09M |
Sector | Health | Technology |
52-Week High | $9.76 | $2.76 |
52-Week Low | $2.78 | $1.59 |
Enterprise Value | $2.58B | $576.02M |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About AbCellera Biologics Inc
AbCellera Biologics Inc is a biotechnology company. It develops antibodies to treat infectious diseases and various other types of diseases. The company's AI-powered technology sources, searches, decodes and analyzes antibody responses to engineer new antibody drug candidates for its partners.
Read more on ABCL →About 8x8 Inc
8x8 is a provider of integrated cloud communications and contact center solutions. Its platform combines voice, video, chat, and contact center functionality into a single application to help businesses collaborate.
Read more on EGHT →
